久久久国产一区二区_欧美在线小视频_高清一区二区三区_久久综合久久久_成人久久久久久久久_亚洲精品视

中美臨床和轉化醫學論壇 SAS-CTM Sino-American Symposium on Clinical and Translational Medicine 
臨床和轉化醫學研究關系到社會整體健康水平的發展, 也同每個國際多中心的臨床試驗密切相關, 藥物研制創新, 更涉及到從實驗室成果轉化成為患者病床前臨床應用的全部過程。

提倡和推進轉化醫學研究是我們所共同關心的提高醫藥衛生健康服務質量的前提和保障。近年來, 在國家重大科技專項和地方科技基金支持下,特別是國家十二五計劃推動和實施，我國將迎來生物醫藥創新發展的新高峰。客觀上, 我國生物醫藥產業的迅猛發展和巨大的健康產業市場, 構成了轉化醫學研究的最佳環境。已成立的十多家轉化醫學中心和數百家醫院的臨床試驗基地承接著國際化多中心臨床研究合作，這些在積極推動著我國轉化醫學發展的腳步, 預示著我國在加快臨床和轉化醫學學科建立的進程同時，開啟了與國際接軌的良好開端。

預測成果轉化對臨床實踐的影響有著極為重要的現實意義。

吸納國際轉化醫學研究和管理經驗, 提供國內轉化醫學交流的平臺。這樣, 我們的科研人員才會更好地根據自身的科研資源, 開展轉化醫學的國際交流與合作。

開拓“臨床和轉化醫學”這個嶄新領域, 為基礎與臨床科研人員提供國內外轉化醫學資訊, 導航轉化型科研項目,將會使我們及時地參考國際轉化醫學發展的路線圖和經驗, 把我們自己的“轉化醫學” 的腳步走得更踏實, 更有實際意義。

Condition, and each international multicenter clinical trial; the innovation of drug development involves the whole process from bench to bedside.
Advocating and promoting translational medicine is the prerequisite and support of developing the quality of medical health service. Recently, supported by the Major National Science-Technology Project and the local science-technology funds, especially the promotion and implement of the 12th five-year national development plan, a new summit of the innovation development of biological medicine will be reached. Objectively, the booming biological medicine and enormous healthcare market cultivate the optimum environment of translational research. More than ten translational research centers and hundreds of clinical centers in the hospitals undertake international and multicenter clinical research collaboration, which makes a good start in connecting to the international while promoting the development of our translational research and indicating that the process of establishing the clinical and translational research science is speeding up.

Predicting the impact of translating research achievements into clinical practice is of great practical and significance.
By exploring this novel domain of Clinical and Translational Research, providing domestic and foreign information of translational research to basic and clinical researchers, and guiding the transformed science and technology research projects, we’ll have a great chance to get the information for reference about the roadmap and experience in the development from international colleagues in time, therefore we can have our own clear and practical footprints of translational medicine.